Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study

This study evaluated 12‐week retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C virus (HCV) infection who did not achieve sustained virologic response after previous treatment with a sofosbuvir‐ and velpatasvir‐containing regimen. All 31 patients maintained a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruane, Peter, Strasser, Simone I., Gane, Edward J., Hyland, Robert H., Shao, Jiang, Dvory‐Sobol, Hadas, Tran, Tram, Stamm, Luisa M., Brainard, Diana M., Nyberg, Lisa, Shafran, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849811/
https://www.ncbi.nlm.nih.gov/pubmed/30663168
http://dx.doi.org/10.1111/jvh.13067
_version_ 1783469284045881344
author Ruane, Peter
Strasser, Simone I.
Gane, Edward J.
Hyland, Robert H.
Shao, Jiang
Dvory‐Sobol, Hadas
Tran, Tram
Stamm, Luisa M.
Brainard, Diana M.
Nyberg, Lisa
Shafran, Stephen
author_facet Ruane, Peter
Strasser, Simone I.
Gane, Edward J.
Hyland, Robert H.
Shao, Jiang
Dvory‐Sobol, Hadas
Tran, Tram
Stamm, Luisa M.
Brainard, Diana M.
Nyberg, Lisa
Shafran, Stephen
author_sort Ruane, Peter
collection PubMed
description This study evaluated 12‐week retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C virus (HCV) infection who did not achieve sustained virologic response after previous treatment with a sofosbuvir‐ and velpatasvir‐containing regimen. All 31 patients maintained a sustained virologic response 12 weeks after the last sofosbuvir/velpatasvir/voxilaprevir dose.
format Online
Article
Text
id pubmed-6849811
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68498112019-11-15 Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study Ruane, Peter Strasser, Simone I. Gane, Edward J. Hyland, Robert H. Shao, Jiang Dvory‐Sobol, Hadas Tran, Tram Stamm, Luisa M. Brainard, Diana M. Nyberg, Lisa Shafran, Stephen J Viral Hepat Short Communication This study evaluated 12‐week retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C virus (HCV) infection who did not achieve sustained virologic response after previous treatment with a sofosbuvir‐ and velpatasvir‐containing regimen. All 31 patients maintained a sustained virologic response 12 weeks after the last sofosbuvir/velpatasvir/voxilaprevir dose. John Wiley and Sons Inc. 2019-02-27 2019-06 /pmc/articles/PMC6849811/ /pubmed/30663168 http://dx.doi.org/10.1111/jvh.13067 Text en © 2019 The Authors. Journal of Viral Hepatitis Published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Short Communication
Ruane, Peter
Strasser, Simone I.
Gane, Edward J.
Hyland, Robert H.
Shao, Jiang
Dvory‐Sobol, Hadas
Tran, Tram
Stamm, Luisa M.
Brainard, Diana M.
Nyberg, Lisa
Shafran, Stephen
Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study
title Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study
title_full Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study
title_fullStr Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study
title_full_unstemmed Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study
title_short Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study
title_sort sofosbuvir/velpatasvir/voxilaprevir for patients with hcv who previously received a sofosbuvir/velpatasvir‐containing regimen: results from a retreatment study
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849811/
https://www.ncbi.nlm.nih.gov/pubmed/30663168
http://dx.doi.org/10.1111/jvh.13067
work_keys_str_mv AT ruanepeter sofosbuvirvelpatasvirvoxilaprevirforpatientswithhcvwhopreviouslyreceivedasofosbuvirvelpatasvircontainingregimenresultsfromaretreatmentstudy
AT strassersimonei sofosbuvirvelpatasvirvoxilaprevirforpatientswithhcvwhopreviouslyreceivedasofosbuvirvelpatasvircontainingregimenresultsfromaretreatmentstudy
AT ganeedwardj sofosbuvirvelpatasvirvoxilaprevirforpatientswithhcvwhopreviouslyreceivedasofosbuvirvelpatasvircontainingregimenresultsfromaretreatmentstudy
AT hylandroberth sofosbuvirvelpatasvirvoxilaprevirforpatientswithhcvwhopreviouslyreceivedasofosbuvirvelpatasvircontainingregimenresultsfromaretreatmentstudy
AT shaojiang sofosbuvirvelpatasvirvoxilaprevirforpatientswithhcvwhopreviouslyreceivedasofosbuvirvelpatasvircontainingregimenresultsfromaretreatmentstudy
AT dvorysobolhadas sofosbuvirvelpatasvirvoxilaprevirforpatientswithhcvwhopreviouslyreceivedasofosbuvirvelpatasvircontainingregimenresultsfromaretreatmentstudy
AT trantram sofosbuvirvelpatasvirvoxilaprevirforpatientswithhcvwhopreviouslyreceivedasofosbuvirvelpatasvircontainingregimenresultsfromaretreatmentstudy
AT stammluisam sofosbuvirvelpatasvirvoxilaprevirforpatientswithhcvwhopreviouslyreceivedasofosbuvirvelpatasvircontainingregimenresultsfromaretreatmentstudy
AT brainarddianam sofosbuvirvelpatasvirvoxilaprevirforpatientswithhcvwhopreviouslyreceivedasofosbuvirvelpatasvircontainingregimenresultsfromaretreatmentstudy
AT nyberglisa sofosbuvirvelpatasvirvoxilaprevirforpatientswithhcvwhopreviouslyreceivedasofosbuvirvelpatasvircontainingregimenresultsfromaretreatmentstudy
AT shafranstephen sofosbuvirvelpatasvirvoxilaprevirforpatientswithhcvwhopreviouslyreceivedasofosbuvirvelpatasvircontainingregimenresultsfromaretreatmentstudy

Ejemplares similares